Skip to content

Cardiac Catheterization in Cardiac Arrest

Role of Early Cardiac Catheterization in Cardiac Arrest

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02587494
Enrollment
75
Registered
2015-10-27
Start date
2017-12-31
Completion date
2018-12-31
Last updated
2017-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Out of Hospital Cardiac Arrest

Brief summary

This is a pilot study that will lead to a large randomized control trial (RCT), to assess whether early versus late or no cardiac catheterization is associated with improved outcomes in out-of-hospital cardiac arrest (OHCA) patients.

Detailed description

A pilot multicenter RCT. The objectives of the study are: To assess whether early (within 12 hours) cardiac catheterization is associated with improved survival, neurologic and cardiovascular outcomes in OHCA patients. Patients will be randomized 1:1 to early cardiac catheterization, performed as early as possible, within 12h post return of spontaneous circulation (ROSC) following OHCA, or to standard practice, which may include medical management without cardiac catheterization or late cardiac catheterization after completion of therapeutic hypothermia. Percutaneous coronary intervention (PCI) is recommended for culprit lesions found on diagnostic angiography. All patients will undergo therapeutic hypothermia started as soon as possible with target temperature below 36°C according to local practice. Other medical management will be according to standard of care

Interventions

PROCEDURECardiac catheterization

Cardiac catheterization / coronary angiography is a diagnostic procedure used to define the coronary anatomy and presence of obstructive coronary lesions or culprit lesions. According to the findings, it may lead to percutaneous coronary intervention (PCI) using stents

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Glasgow Coma Scale score \<8 on hospital admission following OHCA of presumed cardiac cause. * Initial rhythm ventricular tachycardia (VT) / ventricular fibrillation (VF), who achieved ROSC sustained for \>20 consecutive minutes

Exclusion criteria

* ST-elevation on any of the ECGs post resuscitation * Hypothermia \<30°C * Interval from ROSC to screening of \>12h * Suspected or known acute intracranial hemorrhage or stroke

Design outcomes

Primary

MeasureTime frame
Composite of death and poor neurologic outcomes ( Cerebral Performance Category [CPC] score 3-5).30 days

Secondary

MeasureTime frameDescription
Death30 day
CPC scoreup to 30 days
Acute kidney injury- creatinine levels48 hoursNumber of participants with increase in serum creatinine of ≥44.2 μmol/L, or a 25% relative rise in creatinine, within 48 h after contrast exposure42
Myocardial infarction - according to cardiac troponin levels30 daysNumber of participants with myocardial infarction post percutaneous coronary interventions, in accordance with the universal definition of myocardial infarction.
Estimated cost per patient according to length of stay and procedures performed30 days
Bleeding - according to Hb levels30 daysNumber of participant with overt bleeding according to Academic Research Consortium criteria
Composite of death and poor neurologic outcome1 year
Stroke - imaging or pathology30 daysNew stroke following hypothermia confirmed by imaging (computer tomography or magnetic resonance imaging)
Heart failure (NYHA 3-4)30 days
Stent thrombosis by pathology or angiography30 daysNumber of participants with definite stent thrombosis confirmed by angiography or pathology according to the Academic research consortium criteria

Countries

Canada

Contacts

Primary ContactShahar Lavi, MD
shahar.lavi@lhsc.on.ca519-6633611
Backup ContactMistre Alemayehu
mistre.alemayehu@lhsc.on.ca519-6633611

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026